Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 25 entities : Sanofi save search
Koneksa Announces Clinical Pipeline of Validated Digital Biomarkers to Accelerate Life Sciences Research
Published: 2022-10-25 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.03%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
sciences research life biomarkers
Lieping Chen Founds Normunity to Take Pioneering PD-L1 Work to Next Level
Published: 2022-10-25 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.03%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
work
GSK Abandons Cell Therapy Collaboration with Lyell
Published: 2022-10-25 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.03%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
collaboration therapy
AstraZeneca Sees Mixed Results in Phase III EoE Trial
Published: 2022-10-25 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.03%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
trial results
Esophageal Squamous Cell Carcinoma Pipeline Looks Promising as 45+ Companies Working in the Domain, Assesses DelveInsight
Published: 2022-10-25 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.03%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.4%
H: 1.68%
C: 1.38%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
LPTX | $2.96 -1.33% -1.35% 100K
|
Health Technology
|
| O: -3.0%
H: 7.63%
C: 2.55%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.03%
H: 0.72%
C: -0.1%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -0.7%
H: 5.5%
C: 3.97%
BCEL P | $0.0775 0.0% 52K
|
Health Technology
|
| O: 2.76%
H: 1.34%
C: 0.0%
companies cell carcinoma
Normunity Announces $65 Million Series a Financing to Expand the Frontier of Precision Immuno-Oncology With Immune Normalizer Therapies
Published: 2022-10-25 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.03%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.